Sort
82,697 grants matching “vaccine development”
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$3,067,890Dana-Farber Cancer Institute · P01 · FY2002 · CA
Protective Mechanisms Against Pandemic Respiratory Virus
$3,066,309Ann M Arvin · Stanford University · U19 · FY2006 · AI
Case Clinical Trials Unit
$3,065,181Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2014 · AI
ITR: Special Focus on Computer Science and Epidemiology
$3,065,000Fred S Roberts · Rutgers University New Brunswick · · FY2002 · CSE
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,064,926Jerrold J. Ellner · Boston Medical Center · U19 · FY2017 · AI
Clinical Trials of Biodefense Vaccines (Dengue)
$3,063,895Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Bone Marrow Grafting for Leukemia and Lymphoma
$3,062,251Stanford University · P01 · FY2004 · CA
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
$3,061,599Jasmin Anita Tiro · Ut Southwestern Medical Center · UM1 · FY2019 · CA
KwaZulu-Natal Clinical Trials Unit
$3,060,050Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2021 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,059,835Anna Karolina Palucka · Baylor Research Institute · U19 · FY2013 · AI
Ebola Vaccine Development
$3,057,671Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$3,057,531Ignacio E. Sanz · Emory University · U54 · FY2023 · CA
BSL4 Evaluation Core
$3,057,440Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2017 · AI
HIV, TB, and Malaria Vaccine Development for Africa
$3,057,151Duke University · P01 · FY2004 · AI
Case AIDS Clinical Trials Unit
$3,056,995Michael Marcel Lederman · Case Western Reserve University · U01 · FY2009 · AI
Penn Center for AIDS Research
$3,055,816Ronald G Collman · University Of Pennsylvania · P30 · FY2023 · AI
UAB Center for AIDS Research (CFAR)
$3,055,701Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2020 · AI
Genetic & structural basis for viral neutralization:Vaccinia and Influenza virus
$3,055,350Vanderbilt University · N01 · FY2009 · AI
Nanomedicine Center for Nucleoprotein Machines
$3,054,463Gang Bao · Georgia Institute Of Technology · PN2 · FY2010 · EY
Protective Mechanisms Against Pandemic Respiratory Virus
$3,054,173Ann M Arvin · Stanford University · U19 · FY2007 · AI
NIAID VIROLOGY QUALITY ASSURANCE
$3,053,721James Bremer · Rush University Medical Center · N01 · FY2012 · AI
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,052,265Donald K Milton · Univ Of Maryland, College Park · U19 · FY2022 · AI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,050,511Jerrold J. Ellner · Boston Medical Center · U19 · FY2015 · AI
Development of a Nanoemulsion Adjuvant
$3,050,337Ali I. Fattom · Bluewillow Biologics, Inc. · N01 · FY2017 · AI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$3,050,048Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI